Under pressure, Gilead expands Sovaldi licensing deal to four middle-income countries

Media Article 24 Aug 2017

I-MAK co-director and co-founder Tahir Amin offers his take on Gilead’s voluntary licensing deals— “Gilead didn’t do this because it wanted to.”

Join us to stay updated
and help make lifesaving medicines accessible to all